Lena Wu Email and Phone Number
Board Director | Strategic Advisor | CEO | Biotech & Analytical Tools Founder | Business/Corp Development at
@
Eleni Health
Lena Wu's Location
San Francisco Bay Area, United States, United States
Lena Wu's Contact Details
Lena Wu work email
- Valid
- Valid
- Valid
- Valid
- Valid
Lena Wu personal email
n/a
About Lena Wu
Corporate and business development for early stage companies resulting in the creation of a business infrastructure and strategy that can successfully address the challenges of developing and commercializing novel technologies in the life science industrySpecialties: Identification & analysis of market opportunity especially for novel technologies; Fundraising - preparation of business plans, executive summaries, and presentations;Negotiating and executing licenses, service contracts, collaborative agreements; Pharma collabs & licensing;Strategic review and planning; Start-up infrastructure & operations
Lena Wu's Current Company Details
Eleni Health
View
Board Director | Strategic Advisor | CEO | Biotech & Analytical Tools Founder | Business/Corp Development
Lena Wu Work Experience Details
-
Founding Board MemberEleni Health Jan 2024 - PresentSeed stage company developing an AI-powered, drug-free pain management device addressing chronic pain disorders.
-
Executive ChairGate Scientific May 2023 - PresentMilpitas, Ca, UsDeveloping innovative lab equipment that enable great research and clinical lab quality in a point of care solution to improve healthcare decisions -
Chair, Industry Advisory BoardMatterworks Oct 2021 - PresentSomerville, Ma, Us“Pyxis reinvents the metabolomic analysis processes using ML, making it faster, quantitative, and scalable. This allows us to apply metabolomic insights in crucial areas like generating new hypotheses for markers and metabolomic interpretation of underlying cellular and biological data,” says Jack (J.M.) Geremia, PhD, CEO of Matterworks.Read More: https://lnkd.in/evZBjmrk -
Executive ChairMatterworks Jul 2022 - Feb 2023Somerville, Ma, Us
-
Strategic AdvisorMatterworks May 2021 - Sep 2021Somerville, Ma, Us
-
Technical Activities Committee Industry RepresentativeNiimbl | The National Institute For Innovation In Manufacturing Biopharmaceuticals Mar 2023 - PresentNewark, De, Us -
Mentor, Mit Future Founders ProgramMartin Trust Center For Mit Entrepreneurship Jan 2022 - PresentCambridge, Ma, UsFuture Founders Initiative aims to increase female entrepreneurship in biotech.MIT faculty collaborate with members of the Boston-area biotech community to commercialize women’s discoveries and promote female entrepreneurship. -
Board MemberPhizzle Dec 2023 - PresentSan Francisco, California, Us -
MentorEqualize 2022 Program Jan 2022 - Jul 2022A mentor program & pitch competition to empower academic women entrepreneurs. (https://equalize.wustl.edu/)
-
Strategic Advisor, Technology & Biopharm MarketSciex Mar 2021 - May 2022Framingham, Ma, Us -
Vice President And General Manager, IntabioIntabio, Llc - Now Part Of Sciex Jan 2021 - Mar 2021
-
Ceo & President, Co-FounderIntabio Apr 2017 - Jan 2021Intabio is developing a proprietary microfluidic platform that will provide real-time, rapid, and direct characterization of intact protein isoforms.The development and manufacturing of biologics requires high levels of monitoring and testing due to the fact that antibody and recombinant protein drugs are produced in living cells that often introduce unintended structural modifications that can affect efficacy and toxicity. Current testing systems are cumbersome and do not provide the throughput and real-time protein analytics that today’s rapidly growing biopharma industry desperately needs. Constrained by time and resources, and faced with thousands of samples requiring analysis, samples are cherry-picked or pooled for characterization. This strategy leads to incomplete knowledge of the product quality, and potential costly missteps and delays during development. Intabio was founded to address the critical issue in protein analytics and our solution is based on a decade’s worth of deep customer insight. We are developing the Blaze system (bench-top instrument, microfluidic chip, reagent kit) to address the acute pain in biologic product development and manufacturing by providing real-time, rapid, and direct characterization of intact protein isoforms in a simple and easy to use system. Blaze uses a proprietary microfluidic platform to separate and quantitate protein isoforms based on charge heterogeneity, and if an unknown protein peak is identified, Blaze can directly interface with a mass spectrometer (MS) to identify the specific modification. Our proprietary technology provides the unique integration of three analytical techniques for separation, quantitation, and molecular mass identity that are widely used today across development, regulatory approval, and commercial manufacturing to provide characterization of protein quantity, identity, and purity.
-
Board & Business Development AdvisorIntabio Jan 2017 - Apr 2017Real-time protein analytics platform for biological development and manufacturing
-
Business Development AdvisorSienna Biopharmaceuticals Mar 2016 - Apr 2017Westlake Village, Ca, UsMedical dermatology and aesthetics company. Identify, assess and in-license assets suitable for dermatology; R&D management of pre-clinical validation projects. -
Business And Corporate Development ConsultantLw Consulting May 2008 - Apr 2017Operational roles across corporate development, business development, and strategic marketing for early stage companies developing novel technologies targeted for biotech, diagnostic and life science markets. Projects include market opportunity analysis, drafting business plans, raising capital, establishing critical business and operational infrastructure, IP strategy, product development, licensing and commercialization launch strategy development.
-
Ceo & President, Co-FounderRogne Bioscience, Inc. Nov 2014 - Jun 2016Raised 2M+ seed financing, managed operations to complete clinical POC for a first-in-class, anti-inflammatory human peptide as a topically applied treatment for psoriasis, and led strategic partnering efforts. The development program was completed on time (16 mo) and on budget. After negative clinical POC results were obtained, managed all aspects of the company wind down. The intellectual property relating to the Rogne program was transferred to Oxford’s technology licensing organization, Oxford University Innovation.
-
Business AdvisorCytomx Therapeutics Sep 2013 - Mar 2015South San Francisco, Ca, UsCytomX is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody™ therapeutics. Strategic partnering of lead program; technology and asset in-licensing. -
Coo & Corp Dev, Co-FounderRogne Bioscience Jan 2011 - Nov 2014Start-up focused on development of a topically-delivered, naturally-occurring peptide with a novel anti-inflammatory mechanism of action. Demonstration of inhibition of chemotaxis and cytokine release in preclinical models of inflammation, including peritonitis, dermal inflammation, lung inflammation. Initial clinical proof of concept in psoriasis in < 18mo.
-
Vp Corporate DevelopmentCellpoint Diagnostics, Inc Jan 2007 - May 2008UsCancer diagnostic company utilizing a microfluidic device for the capture and analysis of circulating tumor cells. Responsible for collaboration and licensing agreements, financing, product definition and marketing strategy. -
ConsultantLw Consulting Aug 2004 - Jan 2007
-
Stay-At-Home MomNa Aug 2004 - Jan 2007I decided to go into self-employed consulting to give myself greater scheduling flexibility & only work part-time so that I would have more time to spend at home taking care of my 2 young daughters.
-
Business ConsultantDragonfly Biosciences 2006 - 2007
-
Director, Business DevelopmentCaliper Technologies 2000 - 2003Analytical instrument systems based on microfluidic LabChip technology for life sciences and diagnostic market.
-
Sr. Manager, Bus Dev, Research & TechMillennium Pharmaceuticals 1996 - 2000Cambridge, Ma, Us -
Post-DocGenetics Dept, Harvard University Mar 1992 - Jan 1995Yeast Genetics
Lena Wu Skills
Biotechnology
Corporate Development
Start Up Ventures
Business Development
Molecular Diagnostics
Licensing
Strategic Marketing
Customer Development
Lena Wu Education Details
-
Stanford University School Of MedicineMolecular Pharmacology -
Stanford UniversityBiology
Frequently Asked Questions about Lena Wu
What company does Lena Wu work for?
Lena Wu works for Eleni Health
What is Lena Wu's role at the current company?
Lena Wu's current role is Board Director | Strategic Advisor | CEO | Biotech & Analytical Tools Founder | Business/Corp Development.
What is Lena Wu's email address?
Lena Wu's email address is le****@****tlw.com
What schools did Lena Wu attend?
Lena Wu attended Stanford University School Of Medicine, Stanford University.
What skills is Lena Wu known for?
Lena Wu has skills like Biotechnology, Corporate Development, Start Up Ventures, Business Development, Molecular Diagnostics, Licensing, Strategic Marketing, Customer Development.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial